Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 20/20 | 0.79 |
| ▸ | ITGAV | P06756 | 20/20 | 0.79 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12009706 | 0.90 | ITGB3 (0.67) | ITGB3ITGAVITGA2B | |
| SCHEMBL31321063 | 0.89 | ITGB3 (1.00) | ITGB3ITGAVITGA2B | |
| SCHEMBL6946521 | 0.89 | ITGB3 (1.00) | ITGB3ITGAVITGA2B | |
| SCHEMBL245523 | 0.89 | ITGB3 (1.00) | ITGB3ITGAVITGA2B | |
| SCHEMBL13936150 | 0.88 | ITGB3 (0.85) | ITGB3ITGAVITGA2B | |
| SCHEMBL8330074 | 0.86 | ITGB3 (0.87) | ITGB3ITGAVITGA2B | |
| SCHEMBL8739433 | 0.85 | ITGB3 (0.79) | ITGB3ITGAVITGA2B | |
| SCHEMBL8325096 | 0.83 | ITGB3 (1.00) | ITGB3ITGAVITGA2B | |
| SCHEMBL7077881 | 0.81 | ITGB3 (0.73) | ITGB3ITGAVITGA2B | |
| SCHEMBL8327554 | 0.81 | ITGB3 (0.85) | ITGB3ITGAVITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130171074-A1 | TARGETING COMPOUNDS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2013-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130171074-A1 | TARGETING COMPOUNDS | CD47, CD22, FCGR2A | ITGB3 446/4885ITGAV 169/4885ITGA2B 244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.